神经系统中的P2Y受体:药理学,机制和治疗潜力
Jiu Lin1, Xin Su1, Xiaoxia Feng1
1Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, China.
Pharmacology & therapeutics
|February 22, 2026
概括
由UDP-葡萄糖激活的P2Y14受体调节免疫反应和神经炎症. 准这种受体对治疗神经系统疾病如神经病变性疼痛有前途.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- P2Y14受体是一种核酸糖感应G蛋白结合受体.
- 它调节纯能信号传递,免疫激活和炎症基因表达.
- P2Y14在神经系统中表达,导致神经炎症和神经系统疾病.
研究的目的:
- 审查目前关于P2Y14受体结构,信号和药理学的知识.
- 评估P2Y14在神经病痛,脑血管损伤和神经退行性疾病中的作用.
- 讨论P2Y14向治疗的挑战和未来方向.
主要方法:
- 对P2Y14受体现有的文献的审查.
- 对P2Y14在神经疾病中的作用的研究分析.
- 对针对P2Y14的药理学剂的检查.
主要成果:
- 通过P2Y14信号,特别是通过UDP-葡萄糖,促进像STAT1激活这样的炎症级联.
- 为了精确研究其作用,已经开发了P2Y14抗剂.
- 有证据表明P2Y14与神经病痛,脑血管损伤和神经退行有关.
结论:
- P2Y14受体是神经免疫失调的重要治疗点.
- 需要进一步的研究来将P2Y14调制转化为临床干预措施.
- 了解P2Y14的作用对于开发神经疾病治疗方法至关重要.
相关概念视频
G Protein-coupled Receptors
18.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.1K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.3K
Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
G-protein Coupled Receptors
132.7K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
132.7K
Adrenergic Receptors: ɑ Subtype
3.1K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.1K


